Read our experts’ latest thinking on R&D and manufacturing
Our team is always exploring new frontiers in science and its impact on patient treatments. Learn more about the questions we’re asking—and the answers we’ve uncovered so far.
Hybridoma technology is a popular method for antibody discovery, but the conventional approach of using a single inbred mouse strain for immunization fails to generate the diversity and antibody titers needed to maximize the discovery of high-quality...
The combination of the PentaMice® platform and single B cell screening with the Berkeley Lights Beacon® Optofluidic system increases speed to market for monoclonal antibody therapeutics.
The clinical value of biologics for the treatment of many disease indications has been accompanied by phenomenal sales. By 2026, the global market for biologics is projected to increase to $537 billion. However, getting a promising drug candidate fro...
February 28 marks the global observance of Rare Disease Day, a day when we participate in raising awareness and generating change for the global population and their families living with rare diseases.
A conversation with Lee J. Silverberg, Ph.D. Associate Professor of Chemistry, Pennsylvania State University
Partner with Curia for combined expertise, speed and reliability to support the research, development and manufacturing of your mRNA product.
Peptide-based pharmaceuticals have been growing in popularity in recent years, but synthesizing these complex drugs presents expensive environmental challenges.
We offer a robust portfolio of market-leading APIs and world-class capabilities in niche and high-barrier-to-entry technologies.
For many who are new to drug development, the greatest challenge is not necessarily discovering a blockbuster molecule—it’s finding a team capable of carrying that molecule through the complexities that lie between the research lab and the patien...
As pandemic conditions persist, the pharma industry continues to respond as rapidly as possible to bring more vaccine options to the global population. But developing one or more effective vaccines was just the first hurdle to clear. The drug industr...
Watch this webinar to learn why indexing is a useful tool to glean additional information from X-ray powder diffraction data. The expert speaker will discuss the applications of indexing, including demonstrating pure crystalline phase identification...